Tyra Biosciences (TYRA) Shares Outstanding (2020 - 2026)

Tyra Biosciences (TYRA) has 7 years of Shares Outstanding (Entity) data on file, last reported at $59.5 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 12.02% year-over-year to $59.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.5 million (up 12.02% YoY) and the FY2025 annual result came in at $53.7 million, up 5.83% from the prior year.
• Shares Outstanding (Entity) climbed to $59.5 million in Q1 2026, from $53.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $59.5 million in Q1 2026 to a low of $41.7 million in Q1 2022.
• A 5-year average of $48.3 million and a median of $50.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 1792.87% — and 2025, when it grew 0.84%.
• Tracing TYRA's Shares Outstanding (Entity) over 5 years: stood at $42.4 million in 2022, then advanced by 1.58% to $43.0 million in 2023, then climbed by 17.96% to $50.7 million in 2024, then gained by 5.83% to $53.7 million in 2025, then advanced by 10.73% to $59.5 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $59.5 million (Q1 2026), $53.7 million (Q4 2025), and $53.3 million (Q3 2025), per Business Quant data.